文献速递心脑血管急症重症综合管理与镇静镇痛

降压药物类别与非脑叶型脑出血后功能结局的关系

Antihypertensive Medication Class and Functional Outcomes After Nonlobar Intracerebral Hemorrhage.
PubMed 文献 · JAMA Netw Open · 2025-02-03
一句话结论在非脑叶型脑出血存活者中,住院期间启动ACEI或ARB与90天良好功能结局相关(AOR 1.49),其他降压药类别未见此关联。

本研究基于ERICH研究(2010—2015年美国42家医院的病例对照队列)数据,纳入住院期间存活且有协变量和结局数据的非脑叶型脑出血患者1079例,分析住院期间启动不同类别降压药物与90天功能结局(改良Rankin评分0~2分为良好)的关联。结果显示,启动ACEI或ARB与良好功能结局的几率更高相关(AOR 1.49;95%CI 1.08~2.05;P=0.01),其他降压药物类别均与功能结局无关。该关联在多个敏感性分析中一致,且与脑小血管病影像学特征存在交互作用(AOR 3.04;95%CI 1.01~9.19;P=0.049)。在脑叶型脑出血中未观察到任何降压药物类别与功能结局的关联。

要点

  • 非脑叶型脑出血存活者住院期间启动ACEI或ARB与90天良好功能结局相关:AOR 1.49(95%CI 1.08~2.05;P=0.01)。
  • 其他降压药物类别(β受体阻滞剂、钙通道阻滞剂、噻嗪类利尿剂及其他)与90天功能结局均无显著关联。
  • 该关联与脑小血管病影像学特征存在交互作用:AOR 3.04(95%CI 1.01~9.19;P=0.049)。
  • 在脑叶型脑出血患者中,未观察到任何降压药物类别与功能结局的关联。
  • 非脑叶型脑出血组出院时降压药中位数为3种(IQR 2~3种),44.6%的患者在随访时达到良好功能结局。

适用人群与场景

  • ERICH研究纳入的西班牙裔、非西班牙裔黑人和非西班牙裔白人非脑叶型脑出血患者,住院期间存活且有协变量和结局数据者。
  • 排除了因并发症限制降压药选择的个体。
  • 分析数据集来自2010至2015年美国42家医院。

诊断标准与关键阈值

  • 良好功能结局定义为90天改良Rankin评分0~2分(评分范围0分表示无残疾至6分表示死亡)。

研究设计与关键结果

  • 研究类型为基于ERICH研究的队列研究,纳入1561例参与者,其中非脑叶型脑出血1079例,脑叶型脑出血482例。
  • 非脑叶型脑出血组(1079例)平均年龄58.5岁(SD 12.9),男性676例(62.6%),西班牙裔429例(39.8%)、黑人388例(36.0%)、白人262例(24.4%)。
  • 住院期间启动ACEI或ARB者407例(37.7%),β受体阻滞剂419例(38.8%),钙通道阻滞剂503例(46.6%),噻嗪类利尿剂180例(16.7%),其他降压药物277例(25.7%);出院时降压药中位数3种(IQR 2~3)。
  • 随访时481例(44.6%)达到良好功能结局。
  • 启动ACEI或ARB与良好功能结局的几率更高相关:AOR 1.49(95%CI 1.08~2.05;P=0.01)。
  • 其他降压药物类别均与功能结局无显著关联。
  • 与ACEI或ARB的交互作用由脑小血管病影像学特征介导:AOR 3.04(95%CI 1.01~9.19;P=0.049)。
  • 在脑叶型脑出血中未观察到降压药物类别与功能结局的关联。

证据类型、等级与局限

  • 证据类型:基于ERICH研究的队列研究。

对床旁实践的改变

  • 作者认为,该发现支持在高血压性小动脉病中存在药物类别特异性获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Hypertension is the predominant pathology underlying nonlobar intracerebral hemorrhage (ICH), and antihypertensive agents have distinct biological implications for cerebral microvasculature. It is unknown if the class of antihypertensive medications initiated after ICH affects functional outcome beyond blood pressure (BP) control.

OBJECTIVE: To ascertain the association between the class of antihypertensive agents initiated during hospitalization and 90-day functional outcome in nonlobar ICH.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study uses data from the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study, a case-control cohort study investigating ICH risk factors among Hispanic, non-Hispanic Black (hereafter Black), and non-Hispanic White (hereafter White) populations at 42 US hospitals from 2010 to 2015. Data for this analysis were examined from May to September 2024. ERICH study participants were selected for the present analysis if they survived hospitalization and had available covariate and outcome data. Individuals with complications that would limit antihypertensive choice were excluded.

EXPOSURES: Initiation of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), calcium channel blocker, β-blocker, thiazide diuretic, and other antihypertensive medications during index hospitalization.

MAIN OUTCOMES AND MEASURES: Primary outcome was a favorable functional outcome, defined as a 90-day (follow-up) modified Rankin Score score of 0 to 2 (score range: 0 [indicating no disability] to 6 [indicating death]). Mixed-effects logistic regression adjusted for demographic characteristics, medical history, ICH characteristics, BP measurement, total number of antihypertensive medications, and hospitalization site was used to calculate the odds of favorable functional outcome.

RESULTS: Of the 1561 ERICH study participants in the analytic cohort, 1079 had nonlobar and 482 had lobar ICH. Among the 1079 participants in the nonlobar ICH group (mean [SD] age, 58.5 [12.9] years; 676 males [62.6%]; 429 Hispanic [39.8%], 388 Black [36.0%], and 262 White [24.4%] individuals), a total of 407 (37.7%) ACEIs or ARBs, 419 (38.8%) β-blockers, 503 (46.6%) calcium channel blockers, 180 (16.7%) thiazide diuretics, and 277 (25.7%) other antihypertensive classes were initiated during hospitalization (median [IQR], 3 [2-3] agents at discharge). At follow-up, 481 participants (44.6%) had a favorable functional outcome. Initiation of ACEI or ARB was associated with higher odds of favorable functional outcome (adjusted OR [AOR], 1.49; 95% CI, 1.08-2.05; P = .01). No other antihypertensive class was associated with functional outcome. Findings were consistent across several sensitivity analyses. The interaction with ACEI or ARB was mediated by the presence of radiographic features of cerebral small vessel disease (AOR, 3.04; 95% CI, 1.01-9.19; P = .049). No association with class of antihypertensive agent was observed in lobar ICH.

CONCLUSIONS AND RELEVANCE: This large cohort study found that initiation of ACEI or ARB was associated with favorable 90-day functional outcomes after nonlobar ICH. This finding supports a medication class-specific benefit in hypertensive arteriopathy.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Ridha M, Burke JF, Sekar P, et al. Antihypertensive Medication Class and Functional Outcomes After Nonlobar Intracerebral Hemorrhage. JAMA Netw Open. 2025. PMID: 39899295. doi:10.1001/jamanetworkopen.2024.57770

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。